Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

News Daily News

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

Michael O'Riordan

August 26, 2024

Presentation ESC 2022

Sacubitril/Valsartan Versus Ramipril for Patients with Acute Myocardial Infarction: Win-ratio Analysis of the PARADISE-MI Trial

Presenter: Otavio Berwanger

August 29, 2022

JSousa1.cropped (002) in memoriam_header

News Daily News

Stent Pioneer José Eduardo Sousa Dies, Age 88

Shelley Wood

March 14, 2022

Podcast TCTMD Talking Points

The RIVER Trial

November 10, 2021

Antithrombotic therapy does not provide a benefit for clinically stable but symptomatic outpatients with COVID-19, published results of the ACTIV-4b trial affirm. Neither aspirin nor apixaban (Eliquis; Bristol Myers Squibb) at prophylactic or therapeutic doses reduced what were already very low rates of major adverse cardiopulmonary outcomes versus placebo, and both modestly increased bleeding, researchers led by Jean Connors, MD (Brigham and Women’s Hospital, Boston, MA), report in a paper published online

News Daily News

ACTIV-4b: No Antithrombotic Therapy Needed for COVID-19 Outpatients

Todd Neale

October 13, 2021

News Conference News AHA 2020

Rivaroxaban an Option for Patients with Bioprosthetic Mitral Valves and A-fib

Todd Neale

November 14, 2020

Presentation TCT 2019

SECURE-PCI: 1-Year Outcomes From a Randomized Trial of a Loading Dose of Atorvastatin in Patients With ACS and Planned PCI

Presenter: Otavio Berwanger

September 27, 2019

News Conference News ACC 2019

No TREAT for Ticagrelor at 12 Months: Fibrinolysis Patients After STEMI Do Just as Well on Clopidogrel

Shelley Wood

March 19, 2019

Presentation TCT 2018

ACC 2018 Late Breaking Trial #1 - ODYSSEY Outcomes: What I Liked and What I Question

Presenter: Deepak L. Bhatt, Gregg W. Stone, Otavio Berwanger, Peter Juni, Sanjay Kaul, Roxana Mehran, E. Magnus Ohman, Stuart J. Pocock, Giulio Stefanini

September 23, 2018

Presentation TCT 2018

Garbage in Garbage Out: Risks to Big Data Analysis in Interventional Cardiology

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, Otavio Berwanger

September 23, 2018

News Conference News ACC 2018

SECURE-PCI Comes Up Short for Statin Preloading in ACS Patients

Michael O'Riordan

March 11, 2018

News Conference News ACC 2018

TREAT: No Major Bleeds With Ticagrelor in ACS Patients After Fibrinolysis

Shelley Wood

March 11, 2018

News Conference News ACC 2018

ACC 2018, Day Two: Antiplatelets in ACS, Dabigatran in Noncardiac Surgery, and More

Shelley Wood

March 11, 2018

Presentation SOLACI 2013

State of the Art in CIN Prevention: Insights from Recent Trials

Presenter: Otavio Berwanger

July 26, 2013

News Daily News

Subestudio ACT: La NAC No Reduce el Daño Renal en los Pacientes Diabéticos

April 19, 2013

News Daily News

ACT Substudy: NAC Does Not Reduce Kidney Damage in Diabetic Patients

April 19, 2013

Presentation

Acetylcysteine for the Prevention of Renal Outcomes in Patients with Diabetes Undergoing Coronary and Peripheral Angiography

Presenter: Otavio Berwanger

April 18, 2013

News Conference News ACC 2012

Color Coding, Checklists Improve Use of Evidence-Based Strategies for ACS

L.A. McKeown

March 25, 2012

News Daily News

ACT Published: Definitive Results Nix NAC for Preventing Kidney Damage

Caitlin E. Cox

August 26, 2011

Advertisement

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

Sacubitril/Valsartan Versus Ramipril for Patients with Acute Myocardial Infarction: Win-ratio Analysis of the PARADISE-MI Trial

Stent Pioneer José Eduardo Sousa Dies, Age 88

The RIVER Trial

ACTIV-4b: No Antithrombotic Therapy Needed for COVID-19 Outpatients

Rivaroxaban an Option for Patients with Bioprosthetic Mitral Valves and A-fib

SECURE-PCI: 1-Year Outcomes From a Randomized Trial of a Loading Dose of Atorvastatin in Patients With ACS and Planned PCI

No TREAT for Ticagrelor at 12 Months: Fibrinolysis Patients After STEMI Do Just as Well on Clopidogrel

ACC 2018 Late Breaking Trial #1 - ODYSSEY Outcomes: What I Liked and What I Question

Garbage in Garbage Out: Risks to Big Data Analysis in Interventional Cardiology

SECURE-PCI Comes Up Short for Statin Preloading in ACS Patients

TREAT: No Major Bleeds With Ticagrelor in ACS Patients After Fibrinolysis

ACC 2018, Day Two: Antiplatelets in ACS, Dabigatran in Noncardiac Surgery, and More

State of the Art in CIN Prevention: Insights from Recent Trials

Subestudio ACT: La NAC No Reduce el Daño Renal en los Pacientes Diabéticos

ACT Substudy: NAC Does Not Reduce Kidney Damage in Diabetic Patients

Acetylcysteine for the Prevention of Renal Outcomes in Patients with Diabetes Undergoing Coronary and Peripheral Angiography

Color Coding, Checklists Improve Use of Evidence-Based Strategies for ACS

ACT Published: Definitive Results Nix NAC for Preventing Kidney Damage

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content